Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)

Research output: Contribution to journalReview articlepeer-review

160 Scopus citations


Male lower urinary tract symptoms, benign prostatic hyperplasia, enlargement of the prostate, and bladder outlet obstruction are common among aging men and will increase in socioeconomic and medical importance at a time of increased life expectancy and aging of the baby boomer generation. This article reviews the epidemiology, management, and therapeutic options for these conditions. In patients bothered by moderate to severe symptoms, providers can make educated and differential choices between several classes of drugs, alone or in combination, to treat effectively and improve the symptoms in most men. Despite the efficacy of medical therapy, there will be patients who require referral to a urologist either early, to rule out prostate cancer and other conditions, or later, after initial medical therapy and lifestyle management has failed. Perhaps as many as 30% of patients fail to achieve sufficient symptom improvement with medication, lifestyle adjustment, and fluid management, and may require more invasive or surgical treatment options.

Original languageEnglish (US)
Pages (from-to)87-100
Number of pages14
JournalMedical Clinics of North America
Issue number1
StatePublished - Jan 1 2011


  • 5-α-Reductase inhibitors
  • Antimuscarinics
  • Benign prostatic hyperplasia (BPH)
  • Lower urinary tract symptoms (LUTS)
  • Medical therapy
  • α blocker

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)'. Together they form a unique fingerprint.

Cite this